CNB Financial (CCNE) Earnings Analysis
CNB Financial (CCNE) next reports earnings on 2026-07-28, consensus EPS 0.858 USD. Last quarter (2026-04-20) it beat with EPS 0.88 USD vs 0.82 USD est (+7.3%). It has beaten estimates in 7/7 recent quarters (100%). Trailing P/E 11.92.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CCNE next report earnings?
| Next earnings date | 2026-07-28 |
|---|---|
| Consensus EPS estimate | 0.858 USD |
| Revenue estimate | 0.09B |
CCNE earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-20 | 0.88 USD | 0.82 USD | +7.3% | Beat |
| 2026-01-27 | 0.88 USD | 0.77 USD | +14.3% | Beat |
| 2025-10-30 | 0.82 USD | 0.78 USD | +5.1% | Beat |
| 2025-07-22 | 0.63 USD | 0.58 USD | +8.6% | Beat |
| 2025-04-14 | 0.57 USD | 0.53 USD | +7.5% | Beat |
| 2025-01-28 | 0.66 USD | 0.54 USD | +22.2% | Beat |
| 2024-10-21 | 0.61 USD | 0.57 USD | +7% | Beat |
Beat rate: 7/7 (100%) over reported quarters with consensus data.
CCNE valuation and analyst view
| Trailing P/E | 11.92 |
|---|---|
| Trailing EPS | 2.769 USD |
| Price / book | 1.12 |
| Dividend yield | 2.19% |
| Market cap | 1.00B |
| Analyst consensus | Buy (2 buy / 1 hold / 0 sell) |
| Avg price target | 34 USD |
Related research pages
Frequently asked questions
When is CNB Financial (CCNE)'s next earnings date?
CNB Financial is next scheduled to report on 2026-07-28, with a consensus EPS estimate of 0.858 USD and revenue estimate of 0.09B.
Did CCNE beat earnings last quarter?
In its 2026-04-20 report, CCNE posted EPS of 0.88 USD versus a 0.82 USD estimate — a beat of 7.3%.
What is CCNE's earnings track record?
Over the last 7 reported quarters with consensus data, CCNE beat estimates 7 times (100%).
What is CCNE's current P/E ratio and EPS?
CCNE trades at a trailing P/E of 11.92 on trailing EPS of 2.768910322639779 USD.
What do analysts rate CCNE?
Analyst consensus is "Buy" across 3 ratings (0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 34 USD.